Dataset Information


Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death.

ABSTRACT: Ubiquitin-conjugating enzyme E2C (UBE2C) is characterized as a crucial molecule in cancer cell growth that plays an essential role in the development of gliomas, but the detailed mechanisms have not been fully elucidated. In this study, we found that Forkhead box transcription factor M1 (FoxM1) overexpression increased UBE2C expression, whereas FoxM1 suppression inhibited UBE2C expression in glioma cells. In addition, high FoxM1/UBE2C expression was significantly correlated with poor prognosis in glioma. We subsequently demonstrated that UBE2C was a direct transcriptional target of FoxM1, and site-directed mutations markedly down-regulated UBE2C promoter activity. Moreover, UBE2C siRNA (si-UBE2C) significantly induced glioma cell autophagy and increased both mCherry-LC3 punctate fluorescence and LC3B-II/LC3-I expression. Notably, the si-UBE2C-induced decrease in cell viability was markedly inhibited by the autophagy inhibitor bafilomycin A1. The silencing of UBE2C resulted in a distinct inhibition of the PI3K-Akt-mTOR pathway, which functions in the negative modulation of autophagy. Collectively, our findings provide clinical and molecular evidence that FoxM1 promotes glioma progression by enhancing UBE2C transcription and that the inhibition of UBE2C partially induces autophagic glioma cell death. Thus, targeting the FoxM1-UBE2C axis has therapeutic potential in the treatment of gliomas.


PROVIDER: S-EPMC5602297 | BioStudies | 2017-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC5924530 | BioStudies
2019-01-01 | S-EPMC6539744 | BioStudies
2012-01-01 | S-EPMC3524882 | BioStudies
2018-01-01 | S-EPMC6002383 | BioStudies
1000-01-01 | S-EPMC3081207 | BioStudies
1000-01-01 | S-EPMC5323199 | BioStudies
2019-01-01 | S-EPMC6617611 | BioStudies
2018-01-01 | S-EPMC5943485 | BioStudies
2013-01-01 | S-EPMC3753245 | BioStudies
2019-01-01 | S-EPMC6485292 | BioStudies